The outsourced cell therapy consumables market is projected to grow at an annualized rate of 18%, till 2031
Roots Analysis has done a detailed study on Cell Therapy Consumables Market, 2021-2031, covering key aspects of the industry’s evolution and identifying future growth opportunities.
To order this 230+ page report, which
features 110+ figures and 120+ tables, please visit this –
https://www.rootsanalysis.com/reports/cell-therapy-consumables-market/request-sample.html
Key Market Insights
§ At present, more than 60 players worldwide
claim to have the necessary expertise to offer a variety of materials for kit,
media and reagent preparation, for a wide range of cell therapies
§ The market landscape is geographically well
distributed, with several players offering consumable products for research, as well as therapeutic purposes
§ Over time, a number of stakeholders have
established strong brand positions; in future, such companies are anticipated
to contribute the most to the overall revenues generation potential
§ In pursuit of gaining a competitive edge,
industry stakeholders are actively upgrading existing capabilities and
enhancing their consumables-focused product portfolios
§ To keep pace with the growing demand, many
consumable providers have undertaken strategic initiatives, such as entering
into mutually beneficial partnerships and expanding their capacities
§ We expect industry stakeholders to continue
to forge strategic alliances with niche / specialized players engaged in this
domain to further augment their respective product offerings
§ Presently, the demand for cell therapies
exceeds the available capacity of developers; industry players will need to
further increase the capacity to ensure consistent supply
§ As the demand for cell therapies is
indubitably rising, we anticipate the cell therapy consumables market to grow at an annualized
rate of more than 17% in the near future
§ The projected opportunity for cell therapy
consumable providers is likely to be well distributed across different scales
of operations, end-users and key geographical regions
For more information, please visit https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html
Table of Contents
1. PREFACE
1.1. Scope
of the Report
1.2. Research
Methodology
1.3. Key
Questions Answered
1.4. Chapter
Outlines
2. EXECUTIVE
SUMMARY
2.1. Chapter
Overview
3. INTRODUCTION
3.1. Context
and Background
3.2. Chapter
Overview
3.3. Introduction
to Cell Therapies
3.3.1. Comparison
of Cell Therapies and Other Biotechnology Products
3.4. Classification
of Cell Therapy Products
3.5. Overview
of Cell Therapy Development and Manufacturing
3.6. Role
of Raw Materials in Cell Therapy Development
3.7. Type
of Cell Therapy Consumable
3.8. Key
Challenges Associated with Cell Therapy Consumables
3.9. Future
Perspectives
4. MARKET
LANDSCAPE
4.1. Chapter
Overview
4.2. Cell
Therapy Kit Providers: List of Players
4.2.1. Analysis
by Year of Establishment
4.2.2. Analysis
by Company Size
4.2.3. Analysis
by Location of Headquarters
4.2.4. Analysis
by Location of Kits Preparation Facilities
4.2.5. Analysis
by Accreditations Received
4.2.6. Analysis
by Type of End-User
4.2.7. Analysis
by Type of Cell Therapy
4.2.8. Analysis
by Type of Function
4.2.9. Analysis
by Scale of Operation
4.2.10. Analysis
by Application Area
4.2.11. Analysis
by Application Area and Geography (Regional Landscape)
4.3. Cell
Therapy Media Providers: List of Players
4.3.1. Analysis
by Year of Establishment
4.3.2. Analysis
by Company Size
4.3.3. Analysis
by Location of Headquarters
4.3.4. Analysis
by Location of Media Preparation Facilities
4.3.5. Analysis
by Accreditations Received
4.3.6. Analysis
by Type of End-User
4.3.7. Analysis
by Type of Cell Therapy
4.3.8. Analysis
by Media Components
4.3.9. Analysis
by Type of Function
4.3.10. Analysis
by Scale of Operation
4.3.11. Analysis
by Application Area
4.3.12. Analysis
by Application Area and Geography (Regional Landscape)
4.4. Cell
Therapy Reagent Providers: List of Players
4.4.1. Analysis
by Year of Establishment
4.4.2. Analysis
by Company Size
4.4.3. Analysis
by Location of Headquarters
4.4.4. Analysis
by Location of Reagent Preparation Facilities
4.4.5. Analysis
by Accreditations Received
4.4.6. Analysis
by Type of End-User
4.4.7. Analysis
by Type of Cell Therapy
4.4.8. Analysis
by Type of Function
4.4.9. Analysis
by Scale of Operation
4.4.10. Analysis
by Application Area
4.4.11. Analysis
by Application Area and Geography (Regional Landscape)
4.5.
Analysis by Type of Consumable, Type
of Cell Therapy and Application Area (Grid Representation)
5. COMPANY
COMPETITIVENESS ANALYSIS
5.1. Chapter
Overview
5.2. Key
Assumptions and Parameters
5.3. Methodology
5.4. Company
Competitiveness: Kit Providers
5.5. Company
Competitiveness: Media Providers
5.6. Company
Competitiveness: Reagent Providers
6. BRAND
POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter
Overview
6.2. Scope
and Methodology
6.3. Bio-Techne
6.4. Miltenyi
Biotec
6.5. Sartorius
6.6. STEMCELL
Technologies
6.7. Thermo
Fisher Scientific
7. COMPANY
PROFILES
7.1. Chapter
Overview
7.2. Miltenyi
Biotec
7.2.1. Company
Overview
7.2.2. Product
Portfolio
7.2.3. Recent
Developments and Future Outlook
7.3. STEMCELL
Technologies
7.3.1. Company
Overview
7.3.2. Product
Portfolio
7.3.3. Recent
Developments and Future Outlook
7.4. Bio-Techne
7.4.1. Company
Overview
7.4.2. Product
Portfolio
7.4.3. Recent
Developments and Future Outlook
7.5. Irvine
Scientific
7.5.1. Company
Overview
7.5.2. Product
Portfolio
7.5.3. Recent
Developments and Future Outlook
7.6. Thermo
Fisher Scientific
7.6.1. Company
Overview
7.6.2. Product
Portfolio
7.6.3. Recent
Developments and Future Outlook
7.7. Sartorius
7.7.1. Company
Overview
7.7.2. Product
Portfolio
7.7.3. Recent
Developments and Future Outlook
7.8. BD
Biosciences
7.8.1. Company
Overview
7.8.2. Product
Portfolio
7.8.3. Recent
Developments and Future Outlook
7.9. Lonza
7.9.1. Company
Overview
7.9.2. Product
Portfolio
7.9.3. Recent
Developments and Future Outlook
7.10. CellGenix
7.10.1. Company
Overview
7.10.2. Product
Portfolio
7.10.3. Recent
Developments and Future Outlook
7.11. Corning
7.11.1. Company
Overview
7.11.2. Product
Portfolio
7.11.3. Recent
Developments and Future Outlook
8. RECENT
DEVELOPMENTS AND INITIATIVES
8.1. Chapter
Overview
8.2. Partnership
Models
8.3. Cell
Therapy Consumables: Recent Partnerships and Collaborations
8.3.1. Analysis
by Year of Partnership
8.3.2. Analysis
by Type of Partnership
8.3.3. Analysis
by Year and Type of Partnership
8.3.4. Analysis
by Type of Consumable
8.3.5. Analysis
by Type of Partnership and Type of Consumable
8.3.6. Analysis
by Type of Cell Therapy
8.3.7. Analysis
by Type of Consumable and Type of Cell Therapy
8.3.8. Most
Active Players: Analysis by Number of Partnerships
8.3.9. Analysis
by Region
8.3.9.1. Intracontinental and Intercontinental
Agreements
8.3.9.2. Local and International Agreements
8.3.10. Cumulative Year-wise Trend of Merger /
Acquisition
8.3.11. Analysis by Type of Acquisition
8.3.12. Analysis by Key Value Drivers
8.3.13. Analysis by Year of Acquisition and
Key Value Drivers
8.4. Cell
Therapy Consumables: Recent Expansions
8.4.1. Analysis
by Year of Expansion
8.4.2. Analysis
by Purpose of Expansion
8.4.3. Analysis
by Year and Purpose of Expansion
8.4.4. Analysis
by Type of Consumable
8.4.5. Analysis
by Purpose of Expansion and Type of Consumable
8.4.6. Analysis
by Area of Expansion
8.4.7. Analysis
by Region
8.4.7.1. Analysis by Location of Consumable
Facility (Continent-wise)
8.4.7.2. Analysis by Location of Consumable
Facility (Country-wise)
8.4.8. Analysis
by Purpose of Expansion and Location of Headquarters
9. LIKELY
PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter
Overview
9.2. Scoring
Criteria and Key Assumptions
9.3. Scope
and Methodology
9.4. Key
Potential Strategic Partners for Cell Therapy Consumable Providers
9.3.1. Likely
Partner Opportunities for Dendritic Cell Therapy Consumable Providers
9.3.2. Likely
Partner Opportunities for NK Cell Therapy Consumable Providers
9.3.3. Likely
Partner Opportunities for Stem Cell Therapy Consumable Providers
9.3.4. Likely
Partner Opportunities for T-Cell Therapy Consumable Providers
10. DEMAND
ANALYSIS
10.1. Chapter
Overview
10.2. Scope
and Methodology
10.3. Global
Demand for Cell Therapy Consumables
10.4. Global
Demand for Cell Therapy Consumables for Planar Processes
10.5. Global
Demand for Cell Therapy Consumables for Suspension Processes
10.6. Analysis
by Scale of Operation
10.7. Analysis
by Region
11. MARKET
FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter
Overview
11.2. Forecast
Methodology
11.3. Global
Outsourced Cell Therapy Consumables Market, 2021-2031
11.4. Outsourced
Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Consumable
11.4.1. Outsourced
Cell Therapy Consumables Market for Kits, 2021-2031
11.4.2. Outsourced
Cell Therapy Consumables Market for Media, 2021-2031
11.4.3. Outsourced
Cell Therapy Consumables Market for Reagents, 2021-2031
11.5. Outsourced
Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Cell
Therapy
11.5.1. Outsourced
Cell Therapy Consumables Market for Dendritic Cell Therapy, 2021-2031
11.5.2. Outsourced
Cell Therapy Consumables Market for NK Cell Therapy, 2021-2031
11.5.3. Outsourced
Cell Therapy Consumables Market for Stem Cell Therapy, 2021-2031
11.5.4. Outsourced
Cell Therapy Consumables Market for T-Cell Therapy, 2021-2031
11.6. Outsourced
Cell Therapy Consumables Market, 2021-2031: Distribution by Scale of Operation
11.6.1. Outsourced
Cell Therapy Consumables Market for Clinical Operations, 2021-2031
11.6.2. Outsourced
Cell Therapy Consumables Market for Commercial Operations, 2021-2031
11.7. Outsourced
Cell Therapy Consumables Market, 2021-2031: Distribution by Type of End-User
11.7.1. Outsourced
Cell Therapy Consumables Market for Industry Players, 2021-2031
11.7.2. Outsourced
Cell Therapy Consumables Market for Non-Industry Players, 2021-2031
11.8. Outsourced
Cell Therapy Consumables Market, 2021-2031: Distribution by Geography
11.8.1. Outsourced
Cell Therapy Consumables Market in North America, 2021-2031
11.8.2. Outsourced
Cell Therapy Consumables Market in Europe, 2021-2031
11.8.3. Outsourced
Cell Therapy Consumables Market in Asia-Pacific, 2021-2031
11.8.4. Outsourced
Cell Therapy Consumables Market in Rest of the World, 2021-2031
12. UPCOMING
TRENDS AND FUTURE GROWTH OPPORTUNITIES
12.1. Chapter
Overview
12.2. Emerging
Trends Related to Cell Culture Media
12.3. Automation
of Cell Therapy Manufacturing Processes
12.4. Single
Use Systems and Technologies in Cell Therapy Manufacturing
13. IMPACT
OF COVID-19 ON CELL THERAPY CONSUMABLES MARKET
13.1. Chapter
Overview
13.2. Impact
of COVID-19 Pandemic on Cell Therapy Consumables Market
13.3. Impact
on Future Market Opportunities for Cell Therapy Consumable Providers
13.4. Current
Opinions and Key Initiatives of Key Players
13.5. Recuperative
Strategies for Developer Businesses
13.5.1. Strategies
for Implementation in the Short / Mid Term
13.5.2. Strategies
for Implementation in the Long Term
14. CONCLUDING
REMARKS
14.1. Chapter
Overview
15. INTERVIEW
TRANSCRIPTS
15.1. Chapter
Overview
15.2. Anant
Kamath, Chief Operating Officer, Cellular Engineering Technologies
15.2.1. Cellular
Engineering Technologies: Key Highlights
15.2.2. Interview
Transcript
15.3.
Vishal G. Warke, Director R&D,
Cell Culture and Immunology, HiMedia Laboratories and Gauri W. Page, Assistant
R&D Manager, Animal Cell Culture, Himedia Laboratories
15.3.1. HiMedia
Laboratories: Key Highlights
15.3.2. Interview
Transcript
16. APPENDIX
I: TABULATED DATA
17. APPENDIX
II: LIST OF COMPANIES AND ORGANIZATIONS
Contact Details
Ben Johnson
+1 (415) 800 3415
Comments
Post a Comment